“We're just at the cusp of the therapeutic genetic therapeutics revolution, which I think will continue to sweep medicine for the next 15 to 20 years and will completely fundamentally change the way we think about treating all kinds of diseases.”
In this week’s episode of The G Word #sciencepodcast, our CEO Chris Wigley is joined by Prof Sir John Bell, Regius Professor of Medicine at Oxford University. Prof Bell has been extensively involved in the development of research programmes in genomics and genetics as well in the development of a clinical research programme in the UK. He is the founder of the Wellcome Trust Centre for Human Genetics and is the founding director of three biotechnology start-up companies. As well as receiving a number of awards and honours, he has a number of charity positions and was selected to the Vaccine Taskforce in 2020. Prof Bell also assisted in the development of the 100,000 Genome Project at Genomics England.
Today John talks about the new operating model Accelerating Detection of Disease programme. As the leader of the programme, he discusses how it has the potential to transform the way people are treated in cancer. He also discusses how new technologies have improved genomics and how they have transformed our thinking around cancer.